VESTION INC has a total of 14 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Japan. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SENTOCLONE AB, OPEXA THERAPEUTICS and INT STEM CELL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Japan | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Hare Joshua | 6 |
#2 | Chatzistergos Konstantinos | 6 |
#3 | Hare Joshua M | 5 |
#4 | Chatzistergos Konstantinos E | 3 |
#5 | Joshua M Hare | 3 |
#6 | Heldman Alan W | 3 |
#7 | Hatzistergos Konstantinos E | 2 |
#8 | Konstantinos E Hatzistergos | 2 |
#9 | Konstantinos E Chatzistergos | 1 |
Publication | Filing date | Title |
---|---|---|
EP3063267A2 | Cardiac neural crest cells and methods of use thereof | |
US2014369976A1 | Pharmaceutical coposition of cardiac stem cells and mesenchymal stem cells | |
US2015316535A1 | Cardiac stem cells and methods of identifying and using the same |